An outbreak of infections caused by the drug-resistant fungus, Candida auris, in one United Kingdom hospital has been linked to multi-use patient equipment.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Investigational beta-lacatamase inhibitor IMI/REL demonstrates a favorable overall response against certain imipenem-non-susceptible bacterial infections.
Advertisement
Researchers present positive new data from multiple studies of VIBATIV at the 2018 ECCMID conference in Madrid, Spain.
Advertisement
Advertisement
Trending on Contagion Live
1
Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment
2
What the FDA Approval of Bulevirtide (Hepcludex) Means for Chronic Hepatitis D Treatment
3
ASM Microbe Conference: Bringing the Microbiology Community Together
4
Wastewater Surveillance’s Role in Identifying Measles Outbreaks
5